Manufacturing and Production

Showing 15 posts of 5863 posts found.

shire_image

Shire submits dry-eye drug for marketing approval

August 15, 2017 Manufacturing and Production, Sales and Marketing Shire, biotech, drugs, pharma, pharmaceutical

Shire has announced that it has submitted its dry-eye drug, lifitegrast, for European marketing approval. The filing comes after it …
gilead-sciences

Gilead set to open $250m, 23-acre campus

August 15, 2017 Manufacturing and Production Gilead, biotech, drugs, pharma, pharmaceutical

Gilead is set for the grand unveiling of its new facility in La Verne, Southern California, after several years of …
regeneron

Regeneron abandons respiratory syncytial virus therapy after late-stage failure

August 15, 2017 Manufacturing and Production, Research and Development RSV, Regeneron, pharma, pharmaceuticals, respiratory syncytial virus

Regeneron has announced that the failure of suptavumab, its experimental treatment for respiratory syncytial virus (RSV), in late-stage trials, the …

Mundipharma agrees $250m ‘smart chemotherapy’ deal

August 15, 2017 Manufacturing and Production, Sales and Marketing CellAct, Mundipharma, biotech, drugs, pharma, pharmaceutical

A small biotech that has been working on developing one treatment for the last decade has finally seen the fruits …

MSD CEO sparks exodus from Trump’s manufacturing council over Charlottesville violence

August 15, 2017 Manufacturing and Production MSD, Merck, Prsident's American Manufacturing Council, charlottesville, pharma, pharmaceuticals

In a shock move, MSD Chairman and Chief Executive Officer Kenneth Frazier (pictured) has announced that he is to resign …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

August 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Merck, NICE, Parkinson's, biotech, diabetes, pharma, pharmaceutical, top ten

Another week, another busy week in pharma. The last seven days have seen some remarkable strides in the diabetes space, …
rasmus-web

Alvotech recruit new CEO from within

August 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alvotech, biotech, drugs, pharma, pharmaceutical

Alvotech, a biopharmaceutical company focusing on the development and manufacture of based in Reykjavik, Iceland, has replaced outgoing CEO, Eef …
injection-2248377_960_720

Global shortage of hep B vaccine hits UK

August 9, 2017 Manufacturing and Production, Research and Development GSK, MSD, biotech, drugs, hep b, hepatitis B, pharma, pharmaceutical

Only last week it was revealed that the UK would administer all babes with the hepatitis B vaccine to reduce …

Takeda reveals collaboration aimed at bolstering oncology pipeline

August 8, 2017 Manufacturing and Production, Sales and Marketing Molecular Templates, Takeda, biotech, drugs, oncology, pharma, pharmaceutical

It is widely known that Takeda is keen to build its portfolio in oncology and it has made another move …

Merck scores expanded NICE recommendation in head, neck and oral cancer

August 8, 2017 Manufacturing and Production, Sales and Marketing Erbitux, Merck, NICE, biotech, cetuximah, drugs, life sciences, pharma, pharmaceuticals

Merck has announced its approval of NICE’s decision to expand its recommendation of Erbitux (cetuximab) to include its use as …
shire_austria_facility

Shire shifts vaccine facility from Baxalta deal to MSD

August 8, 2017 Manufacturing and Production Baxalta, MSD, Shire, biotech, drugs, pharma, pharmaceutical

As part of Shire’s mega-merger with Baxalta, it suddenly had a massive manufacturing network that spanned 17 sites across seven …
nice_new_london_office_internal_3_web

NICE recommends plaque psoriasis contender for NHS use

August 8, 2017 Manufacturing and Production, Sales and Marketing Almirall, NICE< Skilarence, drugs, life sciences, medicine, pharma, pharmaceuticals, plaque psoriasis, psoriasis

The use of Almirall’s psoriasis drug Skilarence (dimethyl fumarate) on the UK’s NHS is one step closer after NICE gave …
brainss

Biotech’s stock goes down in flames after cannabidiol drug failure

August 8, 2017 Manufacturing and Production, Research and Development GW Pharma, Zynerba, biotech, cannabidoil, drugs, pharma, pharmaceutical

Zynerba Pharmaceuticals had hoped that its anti-seizure therapy could replicate the kind of success leading competitors had achieved in showing …
The Gateway to Local Adoption Series

Latest content